-
Top Narrow Based Indexes For June 20
Monday, June 20, 2011 - 10:39am | 205By 10:35 am, the Dow Jones Industrial Average was up 50.93 points, or 0.42%, to 12,055.29, while the broader Standard & Poor's 500 index had gained 3.19 points, or 0.25%. The NASDAQ composite index rose 3.60 points, or 0.14%. Some of the narrow based indexes that are supporting the markets...
-
NASDAQ Stocks Hitting 52-Week Highs
Monday, June 20, 2011 - 10:07am | 156Oncothyreon Inc (NASDAQ: ONTY) shares rose 0.96% to create a new 52-week high of $8.18. ONTY shares have surged 121.92% over the past 52 weeks, while the S&P 500 index has gained 13.78% in the same period. inContact Inc (NASDAQ: SAAS) shares gained 1.64% to create a new 52-week high of $4.35....
-
Acura Pharmaceuticals Shares Surge On Drug Approval
Monday, June 20, 2011 - 8:47am | 76Shares of Acura Pharmaceuticals Inc (NASDAQ: ACUR) surged about 65% in pre-market trading after the company announced that the US Food and Drug Administration (FDA) had approved a tamper-resistant pain drug owned by Acura and Pfizer Inc (NYSE: PFE). ACUR shares gained 65.37% to $6.40 in pre-market...
-
Acura Pharma Spiking in Pre-Market Trading
Monday, June 20, 2011 - 8:41am | 32Shares of Acura Pharmaceutical (NASDAQ: ACUR) resume trading up 64% after the company receives marketing approval from the FDA for OXECTATM (oxycodone HCl, USP) tablets.
-
Endo Pharmaceuticals Successfully Completes Acquisition of American Medical Systems for $2.9 Billion
Monday, June 20, 2011 - 8:05am | 189Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of American Medical Systems, Inc. Endo announced on April 11, 2011, that it entered into a definitive agreement to acquire AMS, a leading provider of world-class devices and therapies for male and female pelvic...
-
Ligand Enters into Captisol Commercial Supply Agreement with Merck
Monday, June 20, 2011 - 8:03am | 76Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that it has entered into a Captisol® supply agreement with Merck & Co., Inc. (NYSE: MRK) for an undisclosed program. Ligand will supply clinical and commercial supplies of Captisol and, if the program is approved for...
-
Piper Jaffray Reiterates Overweight Rating On Salix Pharmaceuticals
Monday, June 20, 2011 - 7:45am | 165According to Piper Jaffray, Salix Pharmaceuticals (NASDAQ: SLXP) shares reflect minimal expectations for Xifaxan550 in irritable bowel syndrome (IBS) ahead of the 6/20/11 FDA meeting to explore a path forward. Piper Jaffray said that an outcome involving SLXP running a non-randomized study would...
-
Pfizer and Acura Announce FDA Approval of Oxectatm (Oxycodone HCL, USP) CII
Monday, June 20, 2011 - 7:31am | 162Pfizer Inc. (NYSE: PFE) and Acura Pharmaceuticals Inc. (NASDAQ: ACUR) announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM (oxycodone HCl, USP) Tablets CII. OXECTA is indicated for the management of acute and chronic moderate to severe pain where the use of...
-
A Peek Into The Market Before The Trading Starts
Monday, June 20, 2011 - 7:24am | 441Pre-open movers US stock futures are lower this morning, after euro zone finance ministers postponed a decision on a Greek bailout package. Futures on the Dow Jones Industrial Average dipped 52 points to 11,886.00 and futures on the S&P 500 stock index fell 5.60 points to 1,260.40. Nasdaq 100...
-
Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program
Monday, June 20, 2011 - 6:53am | 255Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo Pharmaceuticals (Nasdaq: ENDP), of Chadds Ford, Pa, U.S.A., announced today that they have achieved a late stage discovery milestone in their joint program focused on cancer. This is the third milestone in...
-
Merger Arbitrage Mondays – June 20, 2011
Monday, June 20, 2011 - 4:08am | 4958Merger activity increased last week with seven new deals announced and six closing. This spike in deals announced follows a temporary lull in the week prior where no new deals were announced. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates...
-
Apricus Biosciences' CEO Sees Higher Revenue if Pfizer Viagra Litigation is Successful
Friday, June 17, 2011 - 2:29pm | 152Dr. Bassam Damaj, the Chairman, President and Chief Executive Officer of Apricus Biosciences, Inc. (Nasdaq: APRI) noted today his belief that the specialty biopharmaceutical company could see higher revenues should Pfizer, Inc. (NYSE: PFE) be successful in its patent litigation battle against the...
-
Perrigo Finds Own Brand Of Profits In Generic Drugs
Friday, June 17, 2011 - 12:44pm | 66Today we'll look at Perrigo (PRGO). It's a leader in producing and distributing store-brand versions of popular over-the-counter medications sold at Wal-Mart, Target, Walgreen and other major retailers. As a recent New America article noted, consumers have been switching from branded originals to...
-
TPI Discusses Non-Cash Non-Operational Financial Impact from Warrants
Friday, June 17, 2011 - 10:34am | 229Tianyin Pharmaceutical Co., Inc. (NYSE: TPI) today discussed the non-cash, non-operational financial impact from the warrants issued in January 2008 under the ASC 815-40-15. In the financial report of Third quarter fiscal year 2011 ending March 31, 2011, the Company has disclosed that under ASC...
-
Options Brief: Warner Chilcott plc
Friday, June 17, 2011 - 10:11am | 79Shares of Warner Chilcott plc (NASDAQ: WCRX) are higher on the session by 0.97%, trading at $22.94. Overall put volume is now running at 9.53x the daily average, with 0% of all puts traded being purchases on the offer. 6,166 contracts have traded on the session so far. Warner Chilcott plc. is a...